Business Trends– category –
-
Engineered Allogeneic Treg Cell Therapy TRX103 Enters Phase 1/2a Clinical Trials for Crohn’s Disease and GvHD Prevention
Frontiers Global Overview The gene-edited allogeneic Treg cell therapy candidate TRX103, designed as a scalable, off-the-shelf application, has commenced Phase 1/2a clinical evaluation for Crohn's disease and Graft-versus-Host Disease (G... -
Cellbase Guide: Perfusion Culture Unlocks 10^9 Cells/mL, Revolutionizing Bioreactor Productivity
Cellbase フィンランド Overview Cellbase's new guide on bioreactor scale-up highlights perfusion culture as a critical technology for achieving unprecedented cell densities, often reaching 10^7–10^8 cells/mL and potentially up to 10^9 cel... -
FUJIFILM Completes £400M UK Teesside CDMO Expansion, Accelerating Bioprocess Innovation and Cell Product Diversification
Fujifilm Japan Overview FUJIFILM announced significant life sciences advancements at BIO 2026, notably completing a £400 million investment in its UK Teesside manufacturing facility, making it the largest single-use CDMO site in the coun... -
Advancing Cell Therapy Production: CCRM, OmniaBio, and Avectas Pioneer Automated Hub-and-Spoke Model for CAR-T, iPSC, and Lentiviral Vectors
PR Newswire (CCRM) Canada, アイルランド Overview CCRM and its CDMO subsidiary, OmniaBio, have partnered with Avectas Limited to evaluate an automated, integrated, and scalable cell therapy manufacturing platform. This strategic alliance ... -
Sartorius Revolutionizes Protein Production with Rational CHO Host Cell Engineering: Maximizing Intrinsic Expression Capacity
BioProcess International (Sartorius) Germany Overview Sartorius presented a webcast on rational CHO (Chinese Hamster Ovary) host cell engineering, aiming to significantly boost protein production. Diverging from traditional optimization ... -
Matica Biotechnology and Cirsium Biosciences Partner to Accelerate Flexible AAV Manufacturing via Matica Open Access Platform, Integrating Plant-Based Technology and Single-Use Innovations
BioSpace USA Overview Matica Biotechnology and Cirsium Biosciences announced the adoption of Matica's Open Access Platform to enhance flexibility, transparency, and scalability in Adeno-Associated Virus (AAV) development and manufacturin... -
ACS Publications Reviews Metabolomics-Guided Metabolite Production in Plant Tissue Culture: Integrating Omics and Synthetic Biology for Enhanced Yields
ACS Publications USA Overview A comprehensive review in ACS Publications focuses on metabolomics-guided metabolite production in plant tissue culture (PTC), aiming to enhance yields by integrating omics and synthetic biology. Key solutio... -
Lonza Presents Optimization Strategies to Address Purity and Potency Challenges in In Vivo Lentiviral Vector Development for Cell and Gene Therapies
Biocompare Switzerland Overview Lonza outlined optimization strategies for lentiviral vector (LVV) development for in vivo delivery of cell and gene therapies. Key challenges in LVV development include achieving purity, complexity of val... -
YouTube Video Discusses Cultivated Meat’s Civic Implications: Centralized Production and Patent Ownership’s Impact on Food Security Highlighted
YouTube (NextGen Civic News) USA Overview A NextGen Civic News YouTube video discussed the civic implications of cultivated meat. While Upside Foods and Good Meat have received regulatory approval for cultivated meat in the U.S., concern... -
Mosa Meat’s Mark Post Files for EU Cultivated Meat Approval, Citing Cost Reduction and Plant-Based Media as Key Challenges
Food Navigator Europe Overview Mosa Meat's co-founder Mark Post announced the company has filed for regulatory approval of its cultivated meat products in the European Union, following previous approvals in Singapore, Israel, and the Uni...
